Pharmaceutical Executive-10-17-2007

Pharmaceutical Executive

GSK to Pay $1 Billion for Synta Melanoma Drug

October 17, 2007

News Analysis

0

0

In a blockbuster codevelopment deal, GlaxoSmithKline gains rights to an innovative Phase III melanoma drug.

AstraZeneca Spurs Breast Cancer Awareness with Paper Dolls

October 10, 2007

News Analysis

0

0

New Web site allows users to create tribute dolls for breast cancer survivors. For every doll made, AZ will donate $1 to charity.

Putting the Pressure On

March 14, 2007

News Analysis

0

0

Swiss drug maker gears up to launch first in class Tekturna.

Court Says Agency Must Decide on Generic HGH

April 26, 2006

News Analysis

0

0

A federal district court ruled that FDA cannot fail to rule on a Sandoz's application for approval of omnitrope, a human growth hormone, just because it has no policy for generic biologics. Court watchers say the decision may help other generic biologics move forward in the approvals process.